The US president has announced a new deal that would lower the price of some weight loss medications
A pharmaceutical industry representative collapsed in the Oval Office on Thursday as members of US President Donald Trump’s administration were announcing a new deal for weight-loss medications.
The man was standing behind Trump during the event when his knees appeared to suddenly buckle underneath him. According to media outlets, he was initially identified as Novo Nordisk executive Gordon Finlay. However, the Danish company, which produces Ozempic, Rybelsus, and Wegovy, later denied that it was Finlay.
According to Fox News reporter Jacqui…
Read the full article at RT.COM
